Significant Ownership of Shay Capital LLC

Signature - Title
Elan Foxman - Chief Financial Officer
Location
New York, NY
Summary
This page shows a list of all the recent SCHEDULE 13D/G filings made by Shay Capital LLC.

Notify me when Shay Capital LLC files a new Schedule 13D/G report.

⭐ Subscribe ⭐

Significant Ownership of Shay Capital LLC

Sym Company Class Ownership Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
TLYS Tilly's, Inc. Class A Common Stock, par value $0.001 per share 14.84% $4.98M $975K 3.39M +24.3% Shay Capital LLC 30 Jun 2025
LVTX LAVA Therapeutics NV Common shares, par value (euro) 0.12 per share 9.9% $3.97M 2.6M Shay Capital LLC 19 Sep 2025
NEUP Neuphoria Therapeutics Inc. Common Stock, $0.00001 par value per share 7.3% $2.04M 172K Shay Capital LLC 24 Oct 2025
OKUR OnKure Therapeutics, Inc. Class A Common Stock, par value $0.0001 per share 6.3% $2.06M 810K Shay Capital LLC 15 May 2025
DMYY dMY Squared Technology Group, Inc. Class A Common Stock, par value $0.0001 per share 5.4% $1.74M 125K Shay Capital LLC 26 Sep 2025
CTRN Citi Trends Inc Common stock, par value $0.01 5.1% $9.21M 442K Shay Capital LLC 11 Apr 2025
NVRO Nevro Corp Common Stock, $0.001 par value per share 4.19% $9.18M 1.57M Shay Capital LLC 31 Dec 2024
XELA Exela Technologies, Inc. Common Stock, Par Value $0.0001 per share 0.63% $87.8K 176K Shay Capital LLC 31 Dec 2024

Schedules 13D/G Reported by Shay Capital LLC:

Sym Target Class Ownership Change Current Shares Change Value Reporting name Form Report Period Filing Date
* An asterisk sign (*) next to the price indicates that the price is likely invalid.